Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 3, 1998, Pages 211-216

  Milan, Eveline Pípolo ^a,d   Burattini, Marcelo Nascimento ^a   Kallás, Esper Georges ^a,c   Fischmann, Olga ^b   De O Costa, Paulo Roberto ^c   Colombo, Arnaldo Lopes ^a  

^a Division of Infectious Diseases   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CLINICAL TRIAL; FEMALE; FUNGUS IDENTIFICATION; HUMAN; IN VITRO STUDY; MALE; MOUTH CAVITY; PRIORITY JOURNAL; THRUSH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTIFUNGAL AGENTS; AZOLES; BRAZIL; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; KETOCONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOUTH MUCOSA; MYCOLOGY; PREVALENCE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0032432532     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00107-2     Document Type: Article

References (30)

1. Barchiesi F., Colombo A.L., McGough D.A., Rinaldi M.G. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' Proposed Standard. J Clin Microbiol. 32:1994;2494-2500.
2. Barchiesi F., Najvar L.K., Luther M.F., Scalise G., Rinaldi M.G., Graybill J.R. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. Antimicrob Agents Chemother. 40:1996;1317-1320.
3. Bodey G.P. Azole antifungal agents. Clin Infect Dis. 14:(suppl 1):1992;S161-S169.
4. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 41:(RR-17):1992;1-19.
5. Colombo A.L., Barchiesi F., McGough D.A., Fothergill A.W., Rinaldi M.G. Evaluation of the Etest system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole. J Antimicrob Chemother. 36:1995;93-100.
6. Dronda F., Alonso-Sanz M., Laguna F., Chaves F., Martínez-Suárez J.V., Rodríguez-Tudela J.L., González-López A., Valencia E. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 15:1996;446-452.
7. Dupont B., Denning D.W., Marriott D., Sugar A., Viviani M.A., Sirisanthana T. Mycosis and AIDS patients. J Med Vet Mycol. 32:(suppl 1):1994;65-77.
8. Dupont B., Graybill J.R., Armstrong D., Laroche R., Touzé J.E., Wheat L.J. Fungal infections in AIDS patients. J Med Vet Mycol. 30:(suppl 1):1992;19-28.
9. Espinel-Ingroff A. Clinical relevance of antifungal resistance. Infect Dis Clin North Am. 11:1997;929-945.
10. Hitchcock C.A., Pye G.W., Troke P.F., Johnson E.M., Warnock D.W. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother. 37:1993;1962-1965.
11. Imiam N., Carpenter C.C.J., Mayer K.H., Fisher A., Stein M., Danforth S.B. Hierarchical pattern of mucosal Candida infection in HIV-seropositive woman. Am J Med. 89:1990;142-146.
12. Johnson E.M., Warnock D.W., Luker J., Porter S.R., Scully C. Emergence of azole drug resistance in Candida fluconazole therapy for oral candidosis. J Antimicrob Chemother. 35:1995;103-104.
13. Kreger-Van Rij N.J.W. The Yeasts, a Taxonomic Study. 1984;Elsevier Science Publishers, Amsterdam.
14. Le Guennec R., Reynes J., Mallié M., Pujol C., Janbon F., Bastide J.-M. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients Multilocus enzyme electrophoresis analysis and antifungal susceptibilities . J Clin Microbiol. 33:1995;2732-2737.
15. Lynch D.P. Oral candidiasis History, classification, and clinical presentation . Oral Surg Oral Med Oral Pathol. 78:1994;189-193.
16. Maenza J.R., Keruly J.C., Moore R.D., Chaisson R.E., Merz R.D., Gallant J.E. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus - infected patients. J Infect Dis. 173:1996;219-225.
17. Meneses EA, Sousa AQ, Queiroz TRSB, Peixoto MMLV, Brasil MG, Gambale W, Paula CR (1993) Estudo da microbiota fúngica bucal de pacientes soropositivos para o vírus da imunodeficiência humana (HIV). In: Congresso Brasileiro de Microbiologia, XVII, Santos. Resumos. p. 150 (Resumo no. M7.016).
18. Millon L., Manteaux A., Reboux G., Drobacheff C., Monod M., Barale T., Michel-Briand Y. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients Persistence of Candida albicans strains with the same genotype . J Clin Microbiol. 32:1994;1115-1118.
19. National Committee For Clinical Laboratory Standards (NCCLS) (1997) Publication M27-A: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard. Wayne, PA: NCCLS 17(9):1-28.
20. Persons D.A., Laughlin M., Tanner D., Perfect J., Gockerman J.P., Hathorn J.W. Fluconazole and Candida krusei fungemia. N J Med. 325:1991;1315.
21. Rex J.H., Pfaller M.A., Galgiani J.N., Bortlett M.S., Espinel-Ingroff A., Ghannoum M.A., Lancaster M., Odds F.C., Rinaldi M.G., Walsh T.J., Barry A.L. Development of interpretive breakpoints for antifungal susceptibility testing Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections . Clin Infect Dis. 24:1997;235-247.
22. Rodríguez-Tudela J.L., Martínez-Suárez J.V., Dronda F., Laguna F., Chaves F., Valencia E. Correlation of in-vitro susceptibility test results with clinical response A study of azole therapy in AIDS patients . J Antimicrob Chemother. 35:1995;793-804.
23. Sangeorzan J.A., Bradley S.F., He X., Zarins L.T., Ridenour G.L., Tivalli R.N., Kauffman C.A. Epidemiology of oral candidiasis and HIV-infected patients Colonization, infection, treatment, and emergence of fluconazole resistance . Am J Med. 97:1994;339-346.
24. St-Germain G., Dion C., Espinel-Ingroff A., Ratelle J., Repentigny L. Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV. J Antimicrob Chemother. 36:1995;109-118.
25. Tavitian A., Raufman J.-P., Rosenthal L.E., Weber J., Webber C.A., Dincsoy H.P. Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology. 90:1986;443-445.
26. Torres-Rodríguez J.M. Nuevos hongos patógenos oportunistas emergentes. Rev Iberoamer Micol. 13:(suppl 1):1996;S30-S38.
27. Van Der Walt JP (1971) Criteria and methods used in classification. In: LODDER, J., ed. The Yeasts: A Taxonomic Study, 2nd ed. Ed, Lodder, J. Amsterdam: North-Holland Publishing Company, pp. 35-113.
28. Vanden Bossche H., Marichal P., Odds F.C. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:1994;393-400.
29. Vanden Bossche H., Warnock D.W., Dupont B., Kerridge D., Sen Gupta S., Improvisi L., Marichal P., Odds F.C., Probost F., Ronin O. Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol. 32:(suppl 1):1994;189-202.
30. Warnock DW, Burke J, Cope NJ, Jonhson EM, Von Fraunhofer NA, Wiliams EW (1988) Fluconazole resistance in Candida glabrata. Lancet ii:1310.